Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christopher Scott Insider Profile
4 Followers
Christopher Scott, CFO & Secretary at Iradimed, holds 13.71K shares in Iradimed (Ticker: IRMD). Most recently, Christopher Scott Sold $19,286 shares of Iradimed on Feb 11, 2022 for an estimated value of 965.26K.
Profitable Transactions
4 out of 4 Profitable Transactions
Average Return
+25.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Christopher Scott's holdings
Insider Roles
CFO & Secretary
Roles that Christopher Scott holds in companies
Most Profitable Insider Trade
The most profitable trade made by Christopher Scott
Christopher Scott's Trading History
List of latest transactions for each holding click on a transaction to see Christopher Scott's performance on stock
You May Also Like
Christopher Scott insider profile FAQ
What is the percentage of profitable transactions made by Christopher Scott?
The percentage of profitable transactions made by Christopher Scott is 100%.
What is the average return per transaction made by Christopher Scott?
The average return per transaction made by Christopher Scott is 25.00%.
What stocks does Christopher Scott hold?
Christopher Scott holds: IRMD stocks.
What was Christopher Scott’s latest transaction?
Christopher Scott latest transaction was an Informative Sell of $965.26K.
What was Christopher Scott's most profitable transaction?
Christopher Scott’s most profitable transaction was an Informative Sell of IRMD stock on November 24, 2021. The return on the trade was 31.10%.
What is Christopher Scott's role in Iradimed?
Christopher Scott's role in Iradimed is CFO & Secretary.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.